Stocks · Health care · Pharmaceutical Preparations

Edesa Biotech, Inc.

EDSA Clue Score49
British Columbia, Canada Fiscal year ends September CIK 0001540159 Results filed 13 Aug 2026

What the insiders did Net buying

By person

16 insiders · 72 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pardeep Nijhawan
Chief Executive Officer
$429.66K (31)
—
+$429.66K
6,926,110
$45.70M
+224.9%
der Velden Peter van
10% owner
$450.00K (2)
$787.72K (4)
−$337.72K
2,223,157
$14.67M
+396.5%
Michael J Brooks
President
$84.89K (12)
—
+$84.89K
291,479
$1.92M
—
Frank R. Oakes
Director
—
$77.22K (5)
−$77.22K
47,924
$316.25K
—
Daniel E. Morse
Former Director
—
$38.37K (7)
−$38.37K
20,741
$136.87K
—
Lorin K Johnson
Director
$35.03K (1)
—
+$35.03K
12,786
$84.37K
—
Carlo Sistilli
Director
$10.01K (1)
—
+$10.01K
53,071
$350.21K
—
Peter J. Weiler
Chief Financial Officer
—
—
—
129,609
$855.28K
—
Patrick Marshall
Director
—
—
—
71,666
$472.92K
—
Sean Arthur MacDonald
Director
—
—
—
41,054
$270.91K
—
Joan Chypyha
Director
—
—
—
30,029
$198.16K
+103,448%
Charles Olson V
Director
—
—
—
30,000
$197.97K
—
Da David Liu
Director
—
—
—
24,501
$161.68K
—
Stephen Lemieux
Chief Financial Officer
—
—
—
17,400
$114.82K
—
Kathi Niffenegger
Chief Financial Officer
—
—
—
12,542
$82.76K
+586.5%
Paul William Pay
Director
—
—
—
3,654
$24.11K
—

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 3,467,658 to 9,641,031 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.